These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 16380189)

  • 1. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.
    Amidi M; Romeijn SG; Borchard G; Junginger HE; Hennink WE; Jiskoot W
    J Control Release; 2006 Mar; 111(1-2):107-16. PubMed ID: 16380189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.
    Amidi M; Romeijn SG; Verhoef JC; Junginger HE; Bungener L; Huckriede A; Crommelin DJ; Jiskoot W
    Vaccine; 2007 Jan; 25(1):144-53. PubMed ID: 16973248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination.
    Borges O; Cordeiro-da-Silva A; Romeijn SG; Amidi M; de Sousa A; Borchard G; Junginger HE
    J Control Release; 2006 Sep; 114(3):348-58. PubMed ID: 16905219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
    Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
    Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination.
    Verheul RJ; Slütter B; Bal SM; Bouwstra JA; Jiskoot W; Hennink WE
    J Control Release; 2011 Nov; 156(1):46-52. PubMed ID: 21784113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of neuropeptide loaded trimethyl chitosan nanoparticles for nose to brain delivery.
    Kumar M; Pandey RS; Patra KC; Jain SK; Soni ML; Dangi JS; Madan J
    Int J Biol Macromol; 2013 Oct; 61():189-95. PubMed ID: 23831532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel protein-loaded chondroitin sulfate-chitosan nanoparticles: preparation and characterization.
    Yeh MK; Cheng KM; Hu CS; Huang YC; Young JJ
    Acta Biomater; 2011 Oct; 7(10):3804-12. PubMed ID: 21742066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microencapsulated chitosan nanoparticles for lung protein delivery.
    Grenha A; Seijo B; Remuñán-López C
    Eur J Pharm Sci; 2005; 25(4-5):427-37. PubMed ID: 15893461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal toxicity of selected absorption enhancers.
    Haffejee N; Du Plessis J; Müller DG; Schultz C; Kotzé AF; Goosen C
    Pharmazie; 2001 Nov; 56(11):882-8. PubMed ID: 11817176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of coated nanoparticles for a new mucosal vaccine delivery system.
    Borges O; Borchard G; Verhoef JC; de Sousa A; Junginger HE
    Int J Pharm; 2005 Aug; 299(1-2):155-66. PubMed ID: 15998569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLGA:poloxamer and PLGA:poloxamine blend nanostructures as carriers for nasal gene delivery.
    Csaba N; Sánchez A; Alonso MJ
    J Control Release; 2006 Jun; 113(2):164-72. PubMed ID: 16759732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterisation of chitosan nanoparticles for siRNA delivery.
    Katas H; Alpar HO
    J Control Release; 2006 Oct; 115(2):216-25. PubMed ID: 16959358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release.
    Park JS; Han TH; Lee KY; Han SS; Hwang JJ; Moon DH; Kim SY; Cho YW
    J Control Release; 2006 Sep; 115(1):37-45. PubMed ID: 16935380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
    Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
    Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
    Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmucosal macromolecular drug delivery.
    Prego C; García M; Torres D; Alonso MJ
    J Control Release; 2005 Jan; 101(1-3):151-62. PubMed ID: 15588901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate.
    Wu Y; Yang W; Wang C; Hu J; Fu S
    Int J Pharm; 2005 May; 295(1-2):235-45. PubMed ID: 15848008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of nanoparticles composed of chitosan/poly-gamma-glutamic acid and evaluation of their permeability through Caco-2 cells.
    Lin YH; Chung CK; Chen CT; Liang HF; Chen SC; Sung HW
    Biomacromolecules; 2005; 6(2):1104-12. PubMed ID: 15762683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of folate-chitosan-DNA nanoparticles for gene therapy.
    Mansouri S; Cuie Y; Winnik F; Shi Q; Lavigne P; Benderdour M; Beaumont E; Fernandes JC
    Biomaterials; 2006 Mar; 27(9):2060-5. PubMed ID: 16202449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and evaluation of a nanoparticulate system prepared by biodegradable polymers for oral administration of protein drugs.
    Sahu SK; Prusty AK
    Pharmazie; 2010 Nov; 65(11):824-9. PubMed ID: 21155389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.